Latest rheumatoid arthritis Stories
polyDNA’s newest survey for the month of May discovered that 36% of respondents with arthritis wanted to know if EBV is the cause of their disease.
COVA322 is First of Covagen's Bispecific FynomAbs to Enter Clinical Trials ZURICH-SCHLIEREN, Switzerland, May 5, 2014 /PRNewswire/ --
VANCOUVER, May 1, 2014 /CNW/ - Successful organizations are paying more attention to the needs of employees living with arthritis, underlining the significant role 4.6 million Canadians living
- Patented biomarker test designed to predict, monitor and improve patient outcomes PETACH TIKVA, Israel, April 21, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
“The Original Copper Heeler”, a copper insole designed to manage the debilitating
New webinar will focus on scientific and process improvements that advance Rheumatoid Arthritis (RA) drug development.
In May, over three dozen nonprofits around the world, along with thousands of patients, supporters, practitioners, and researchers, will unite under one ‘virtual roof’ to participate in the
The latest in Osteoporosis Risk Assessment and Treatment was discussed with Primary Care practitioners at the 8th Annual Spring CME (Continuing Medical Education) Conference held by the Continuing
- Large; stout; burly.